Palo Alto Investors’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$134K Hold
2024
Q4
$257K Sell
2024
Q3
$2.37M Hold
2024
Q2
$2.2M Hold
2024
Q1
$3.41M Hold
2023
Q4
$3.03M Hold
2023
Q3
$2.2M Hold
2023
Q2
$1.8M Buy
2023
Q1
$1.23M Buy